The Michael J. Fox Foundation's Board of Directors is composed of world leaders in science, business, fundraising, and entertainment. Their expertise helps forge our path ahead, assess our impact, and guide our pursuit of improved Parkinson's treatments and, ultimately, a cure.
Michael J. Fox, Founder
The Michael J. Fox Foundation for Parkinson's Research
George E. Prescott, Chairman
GP Management Services
David Golub, Vice Chairman
Golub Capital
Holly S. Andersen, MD
Assistant Professor of Medicine and Attending Cardiologist
Cornell Cardiology Associates
Eva Andersson-Dubin, MD
Internist
NBC Medical
Jon Brooks
General Partner
JMB Capital Partners
Barry Cohen
Senior Managing Director
Apollo Capital Management
Donny Deutsch
Chairman
Deutsch Inc.
David Einhorn
President
Greenlight Capital
Karen Finerman
President
Metropolitan Capital Advisors, Inc.
Nelle Fortenberry
Television Producer
Albert B. Glickman
Albert B. Glickman and Associates
John A. Griffin
President
Blue Ridge Capital
Skip Irving
Partner and Managing Director
Health Advances, LLC
Jeffrey Katzenberg
CEO
DreamWorks Animation SKG
Kathleen Kennedy
Partner
Kennedy Marshall Company
Morton M. Kondracke
Editor
Roll Call
Edwin A. Levy
Co-Founder and Chairman
Levy, Harkins, & Co., Inc.
Kenneth Olden, PhD, ScD, LHD
Chief, Metastasis Section, LMC
National Institute of Environmental Health Sciences/NIH
Douglas I. Ostrover
Founding Member
GSO Capital Partners
Tracy Pollan
Actress
Frederick E. Rowe (Shad)
President
Rowe & Companies and Greenbrier Partners, Ltd.
Lily Safra
President
Edmond J. Safra Philanthropic Foundation
Curtis Schenker
CEO
Scoggin Capital Management
Woody Shackleton
Retired Sales Executive
Donna E. Shalala, PhD
President
University of Miami
Daniel E. Spitzer, MD
Columbia College of Physicians and Surgeons
Fred G. Weiss
Managing Director
FGW Associates
